371765-69-4 Usage
Uses
Used in Pharmaceutical Synthesis:
2(1H)-Pyridinone,4-(hydroxymethyl)-1-methyl-(9CI) is utilized as a key building block in the synthesis of a variety of pharmaceuticals and organic compounds. Its unique structure and reactivity make it a valuable component in the development of new drugs and chemical entities.
Used in Drug Discovery:
In the field of drug discovery, 2(1H)-Pyridinone,4-(hydroxymethyl)-1-methyl-(9CI) is employed for its potential biological activities. Its anti-inflammatory and anti-cancer properties have been the subject of research, with the aim of identifying and developing new therapeutic agents for the treatment of various diseases and conditions.
Used in Organic Chemistry Research:
2(1H)-Pyridinone,4-(hydroxymethyl)-1-methyl-(9CI) is also used in organic chemistry research to explore its chemical properties and reactivity. This knowledge can contribute to the advancement of organic chemistry and the development of new synthetic methods and applications for 2(1H)-Pyridinone,4-(hydroxymethyl)-1-methyl-(9CI).
Check Digit Verification of cas no
The CAS Registry Mumber 371765-69-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,1,7,6 and 5 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 371765-69:
(8*3)+(7*7)+(6*1)+(5*7)+(4*6)+(3*5)+(2*6)+(1*9)=174
174 % 10 = 4
So 371765-69-4 is a valid CAS Registry Number.
InChI:InChI=1/C7H9NO2/c1-8-3-2-6(5-9)4-7(8)10/h2-4,9H,5H2,1H3
371765-69-4Relevant academic research and scientific papers
Substituted Pyrrolidine Amides I
-
, (2019/07/03)
The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE
-
Page/Page column 156-157, (2010/08/08)
The invention relates to thiazole compounds of Formula (I) and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
Substituted phenyl farnesyltransferase inhibitors
-
, (2012/09/25)
Compounds of formula (I) or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
